Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Recombinant zoster vaccine for the prevention of herpes zoster and post-herpetic neuralgia
Drug guidance

Recombinant zoster vaccine for the prevention of herpes zoster and post-herpetic neuralgia

Infections

Vaccines

10 February 2025

Guidance Recommendations

Subsidy status

Back to top